Related Experiment Video
Updated: Mar 14, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling
Guillaume Andrieu1, Anna H Tran1, Katherine J Strissel1
1Cancer Center, Boston University School of Medicine, Boston, Massachusetts.
Abstract:
The bromodomain and extraterminal (BET) proteins are epigenetic "readers" of acetylated histones in chromatin and have been identified as promising therapeutic targets in diverse cancers. However, it remains unclear how individual family members participate in cancer progression and small molecule inhibitors such as JQ1 can target functionally independent BET proteins. Here, we report a signaling pathway involving BRD4 and the ligand/receptor pair Jagged1/Notch1 that sustains triple-negative breast cancer migration and invasion. BRD4, but not BRD2 or BRD3, regulated Jagged1 expression and Notch1 signaling. BRD4-selective knockdown suppressed Notch1 activity and impeded breast cancer migration and invasion. BRD4 was required for IL6-stimulated, Notch1-induced migration and invasion, coupling microenvironment inflammation with cancer propagation. Moreover, in patients, BRD4 and Jagged1 expression positively correlated with the presence of distant metastases. These results identify a BRD4/Jagged1/Notch1 signaling pathway that is critical for dissemination of triple-negative breast cancer. Cancer Res; 76(22); 6555-67. ©2016 AACR.
Insights
Bromodomain and extraterminal domain (BET) protein BRD4 drives triple-negative breast cancer invasion via the Jagged1/Notch1 pathway. Targeting BRD4 may inhibit cancer metastasis and progression.
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Oncology
Background:
- Bromodomain and extraterminal (BET) proteins are epigenetic readers involved in cancer.
- Understanding individual BET protein roles is crucial for targeted cancer therapies.
- JQ1 is a small molecule inhibitor targeting BET proteins.
Purpose of the Study:
- To investigate the role of individual BET proteins in triple-negative breast cancer (TNBC) progression.
- To identify signaling pathways regulated by BET proteins in TNBC.
- To explore the therapeutic potential of targeting specific BET proteins in TNBC.
Main Methods:
- Utilized BRD4-selective knockdown in TNBC cells.
- Assessed Jagged1 expression and Notch1 signaling activity.
- Investigated the impact of BRD4 on IL6-stimulated migration and invasion.
- Correlated BRD4 and Jagged1 expression with patient metastasis data.
Main Results:
- BRD4, not BRD2 or BRD3, regulated Jagged1 expression and Notch1 signaling in TNBC.
- BRD4 knockdown suppressed Notch1 activity, impeding cancer cell migration and invasion.
- BRD4 was essential for IL6-stimulated and Notch1-induced migration and invasion.
- Elevated BRD4 and Jagged1 expression correlated with distant metastases in patients.
Conclusions:
- A BRD4/Jagged1/Notch1 signaling pathway critically drives TNBC cell migration, invasion, and dissemination.
- BRD4 plays a specific and essential role in TNBC progression.
- This pathway represents a potential therapeutic target for inhibiting TNBC metastasis.
More Related Videos
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Notch Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

